{
    "Trade/Device Name(s)": [
        "Cliniqa Beta HCG Control Level 1",
        "Cliniqa Beta HCG Control Level 2",
        "Cliniqa Beta HCG Control Level 3",
        "Cliniqa Beta HCG Calibration Verification Control Level 1",
        "Cliniqa Beta HCG Calibration Verification Control Level 2",
        "Cliniqa Beta HCG Calibration Verification Control Level 3"
    ],
    "Submitter Information": "Cliniqa Corporation",
    "510(k) Number": "K121237",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022232"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "April 23, 2012",
    "Summary Letter Received Date": "April 24, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Beta HCG"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Calibration Verification Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Cliniqa Beta HCG Control and Calibration Verification Controls Levels 1, 2, 3 as assayed quality control materials for Beta HCG assay precision monitoring",
    "Indications for Use Summary": "Assayed quality control materials used to monitor the precision of Beta HCG assays",
    "fda_folder": "Clinical Chemistry"
}